3D printing is aiding an Israel-based company in the development and production of special selective-dose inhalers for medical marijuana and other medicinal plants. Nano Dimension (Ness Ziona, Israel)—which makes 3D printers for printed circuit boards—announced today that it has leased a DragonFly 2020 3D printer to Syqe Medical (Tel Aviv, Israel). Syqe boasts that it has created the […]
Business/Financial News
Medtech stores we missed this week: March 10, 2017
The FDA and Health Canada cleared a couple medical devices while other companies touted their device studies. Here are medtech stories we missed this week but were still worth mentioning. 1. FDA clears Medela’s neonatal enteral feeding device Medela has received 510(k) clearance from the FDA to market its ENFit Low Dose Tip eternal syringes, […]
Pulmatrix shares droop on growing losses in FY2016 earnings report
Shares in Pulmatrix (NSDQ:PULM) fell today after the medical device maker posted earnings that showed losses growing while revenue shrunk compared with the prior year. The Lexington, Mass.-based company posted losses of $27.8 million, or $1.88 per share, on sales of $835,000 for the full year, with losses growing 6.4% while revenue shrunk 30.5% when compared […]
Orthofix’s foreign corruption woes: Here’s what you can learn
Marc Alain Bohn, Miller & Chevalier Orthofix International in January entered into its second Foreign Corrupt Practices Act (FCPA) settlement in less than 5 years, resolving allegations with the U.S. Securities and Exchange Commission that the company’s Brazilian subsidiary made improper payments to doctors at government-owned hospitals in Brazil to increase sales. Orthofix consented to the entry […]
Baxter reveals DoJ probe of Tisseel, Artiss sealants
Baxter (NYSE:BAX) this week said it received a civil investigative demand from the US Dept. of Justice’s Commercial Litigation Branch related to its Tisseel and Artiss products. The Deerfield, Ill.-based company said the inquiry relates to contingent discount arrangements and other promotions for the 2 sealant products, and that it was cooperating with the DoJ on […]
Medical device companies report sales increases in 2016
By Stewart Eisenhart, Emergo Group One third of all medical device companies participating in a recent Emergo industry survey reported sales increases of 10% or more for 2016. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not necessarily reflect those […]
Medtech stories we missed: Feb. 10, 2017
From Glytec partnering to beat diabetes to Biolase, Gramercy Extremity Orthopedics and more getting FDA clearances, here are 7 recent medtech stories we missed this week, but were still worth mentioning. 1. BioTime proposes public offering of common stock Clinical-stage biotechnology company BioTech is intending to offer common stock shares in an underwritten public offering. BioTime focuses […]
Foster Delivery Science and ProMed Pharma partner for drug delivery applications
Foster Delivery Science and ProMed Pharma have partnered commercially for comprehensive contract services for pharmaceutical and combination device applications. The companies plan to offer thermoplastic and silicone formulation development through the production of drug delivery components. Foster Delivery Science offers blending and extrusion of melt processable polymers and active pharmaceutical ingredients like water soluble, bioresorbable and biodurable thermoplastic […]
How Trelleborg is getting the most out of its acquisitions—including with combo devices
Heather Thompson, Senior Editor As is the case with many medical device industry suppliers, Trelleborg has engaged in a spate of acquisitions to better serve the growing needs of its OEM customers for drug-device combo products and more. Last year, Trelleborg, Sweden–based Trelleborg announced the acquisition of Tustin, California–based Specialty Silicone Fabricators. They’ve made three […]
Teva Pharma CEO Vigodman steps down | Personnel Moves, February 7, 2017
Teva Pharmaceuticals (NYSE:TEVA) said this week that CEO Erez Vigodman has stepped down from their position at the head of the world’s biggest generic drugmaker. Vigodman’s exit from the company will take effect immediately, with board chair Yitzhak Peterburg taking on the interim role of chief exec. Israel-based Teva has seen shares plummet after a series of […]
